nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—NT5E—cardiovascular system—nicotine dependence	0.0354	0.141	CbGeAlD
Pentoxifylline—Sleep disturbance—Varenicline—nicotine dependence	0.0343	0.0564	CcSEcCtD
Pentoxifylline—NT5E—midbrain—nicotine dependence	0.0276	0.11	CbGeAlD
Pentoxifylline—Scotoma—Varenicline—nicotine dependence	0.0253	0.0416	CcSEcCtD
Pentoxifylline—ADORA2A—cardiovascular system—nicotine dependence	0.0252	0.101	CbGeAlD
Pentoxifylline—PDE5A—cardiovascular system—nicotine dependence	0.023	0.0918	CbGeAlD
Pentoxifylline—ADORA1—cardiovascular system—nicotine dependence	0.0218	0.087	CbGeAlD
Pentoxifylline—Lacrimation increased—Varenicline—nicotine dependence	0.0208	0.0343	CcSEcCtD
Pentoxifylline—Eructation—Varenicline—nicotine dependence	0.0189	0.0311	CcSEcCtD
Pentoxifylline—Influenza like illness—Varenicline—nicotine dependence	0.0187	0.0307	CcSEcCtD
Pentoxifylline—Salivary hypersecretion—Varenicline—nicotine dependence	0.0187	0.0307	CcSEcCtD
Pentoxifylline—NT5E—brain—nicotine dependence	0.0174	0.0694	CbGeAlD
Pentoxifylline—ADORA1—midbrain—nicotine dependence	0.017	0.0679	CbGeAlD
Pentoxifylline—Sleep disorder—Varenicline—nicotine dependence	0.0161	0.0265	CcSEcCtD
Pentoxifylline—ADORA2B—brain—nicotine dependence	0.0149	0.0594	CbGeAlD
Pentoxifylline—Thirst—Varenicline—nicotine dependence	0.0147	0.0241	CcSEcCtD
Pentoxifylline—PDE4A—brain—nicotine dependence	0.0133	0.053	CbGeAlD
Pentoxifylline—PDE4B—midbrain—nicotine dependence	0.0126	0.0503	CbGeAlD
Pentoxifylline—ADORA2A—brain—nicotine dependence	0.0124	0.0494	CbGeAlD
Pentoxifylline—Abdominal distension—Varenicline—nicotine dependence	0.0121	0.02	CcSEcCtD
Pentoxifylline—Angina pectoris—Varenicline—nicotine dependence	0.0117	0.0193	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Varenicline—nicotine dependence	0.0116	0.019	CcSEcCtD
Pentoxifylline—PDE5A—brain—nicotine dependence	0.0113	0.045	CbGeAlD
Pentoxifylline—Infestation—Varenicline—nicotine dependence	0.0107	0.0177	CcSEcCtD
Pentoxifylline—Infestation NOS—Varenicline—nicotine dependence	0.0107	0.0177	CcSEcCtD
Pentoxifylline—ADORA1—brain—nicotine dependence	0.0107	0.0427	CbGeAlD
Pentoxifylline—Conjunctivitis—Varenicline—nicotine dependence	0.0104	0.0172	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Varenicline—nicotine dependence	0.0102	0.0167	CcSEcCtD
Pentoxifylline—Epistaxis—Varenicline—nicotine dependence	0.0101	0.0167	CcSEcCtD
Pentoxifylline—Immune system disorder—Varenicline—nicotine dependence	0.00871	0.0143	CcSEcCtD
Pentoxifylline—Arrhythmia—Varenicline—nicotine dependence	0.00862	0.0142	CcSEcCtD
Pentoxifylline—Erythema—Varenicline—nicotine dependence	0.0084	0.0138	CcSEcCtD
Pentoxifylline—Flatulence—Varenicline—nicotine dependence	0.00828	0.0136	CcSEcCtD
Pentoxifylline—Dysgeusia—Varenicline—nicotine dependence	0.00822	0.0135	CcSEcCtD
Pentoxifylline—Back pain—Varenicline—nicotine dependence	0.00812	0.0134	CcSEcCtD
Pentoxifylline—Muscle spasms—Varenicline—nicotine dependence	0.00807	0.0133	CcSEcCtD
Pentoxifylline—Vision blurred—Varenicline—nicotine dependence	0.00791	0.013	CcSEcCtD
Pentoxifylline—PDE4B—brain—nicotine dependence	0.0079	0.0316	CbGeAlD
Pentoxifylline—Tremor—Varenicline—nicotine dependence	0.00787	0.0129	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Varenicline—nicotine dependence	0.00779	0.0128	CcSEcCtD
Pentoxifylline—Anaemia—Varenicline—nicotine dependence	0.00776	0.0128	CcSEcCtD
Pentoxifylline—Agitation—Varenicline—nicotine dependence	0.00772	0.0127	CcSEcCtD
Pentoxifylline—Angioedema—Varenicline—nicotine dependence	0.00767	0.0126	CcSEcCtD
Pentoxifylline—Malaise—Varenicline—nicotine dependence	0.00757	0.0125	CcSEcCtD
Pentoxifylline—Palpitations—Varenicline—nicotine dependence	0.00742	0.0122	CcSEcCtD
Pentoxifylline—Convulsion—Varenicline—nicotine dependence	0.00728	0.012	CcSEcCtD
Pentoxifylline—Hypertension—Varenicline—nicotine dependence	0.00725	0.0119	CcSEcCtD
Pentoxifylline—Myalgia—Varenicline—nicotine dependence	0.00715	0.0118	CcSEcCtD
Pentoxifylline—Chest pain—Varenicline—nicotine dependence	0.00715	0.0118	CcSEcCtD
Pentoxifylline—Anxiety—Varenicline—nicotine dependence	0.00713	0.0117	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.0071	0.0117	CcSEcCtD
Pentoxifylline—Discomfort—Varenicline—nicotine dependence	0.00706	0.0116	CcSEcCtD
Pentoxifylline—Dry mouth—Varenicline—nicotine dependence	0.00699	0.0115	CcSEcCtD
Pentoxifylline—Oedema—Varenicline—nicotine dependence	0.00685	0.0113	CcSEcCtD
Pentoxifylline—Infection—Varenicline—nicotine dependence	0.00681	0.0112	CcSEcCtD
Pentoxifylline—Shock—Varenicline—nicotine dependence	0.00674	0.0111	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Varenicline—nicotine dependence	0.00671	0.011	CcSEcCtD
Pentoxifylline—Tachycardia—Varenicline—nicotine dependence	0.00669	0.011	CcSEcCtD
Pentoxifylline—Skin disorder—Varenicline—nicotine dependence	0.00666	0.011	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Varenicline—nicotine dependence	0.00663	0.0109	CcSEcCtD
Pentoxifylline—Anorexia—Varenicline—nicotine dependence	0.00653	0.0108	CcSEcCtD
Pentoxifylline—Hypotension—Varenicline—nicotine dependence	0.0064	0.0105	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00624	0.0103	CcSEcCtD
Pentoxifylline—Insomnia—Varenicline—nicotine dependence	0.0062	0.0102	CcSEcCtD
Pentoxifylline—Dyspnoea—Varenicline—nicotine dependence	0.00611	0.0101	CcSEcCtD
Pentoxifylline—Somnolence—Varenicline—nicotine dependence	0.00609	0.01	CcSEcCtD
Pentoxifylline—Dyspepsia—Varenicline—nicotine dependence	0.00603	0.00993	CcSEcCtD
Pentoxifylline—Decreased appetite—Varenicline—nicotine dependence	0.00596	0.0098	CcSEcCtD
Pentoxifylline—Constipation—Varenicline—nicotine dependence	0.00586	0.00964	CcSEcCtD
Pentoxifylline—Feeling abnormal—Varenicline—nicotine dependence	0.00565	0.00929	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Varenicline—nicotine dependence	0.0056	0.00922	CcSEcCtD
Pentoxifylline—Urticaria—Varenicline—nicotine dependence	0.00545	0.00896	CcSEcCtD
Pentoxifylline—PDE4A—Opioid Signalling—OPRM1—nicotine dependence	0.00544	0.0383	CbGpPWpGaD
Pentoxifylline—Abdominal pain—Varenicline—nicotine dependence	0.00542	0.00892	CcSEcCtD
Pentoxifylline—Body temperature increased—Varenicline—nicotine dependence	0.00542	0.00892	CcSEcCtD
Pentoxifylline—ADORA1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00515	0.0363	CbGpPWpGaD
Pentoxifylline—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00511	0.036	CbGpPWpGaD
Pentoxifylline—Hypersensitivity—Varenicline—nicotine dependence	0.00505	0.00831	CcSEcCtD
Pentoxifylline—PDE4B—Opioid Signalling—OPRM1—nicotine dependence	0.00503	0.0354	CbGpPWpGaD
Pentoxifylline—Asthenia—Varenicline—nicotine dependence	0.00492	0.00809	CcSEcCtD
Pentoxifylline—Pruritus—Varenicline—nicotine dependence	0.00485	0.00798	CcSEcCtD
Pentoxifylline—Diarrhoea—Varenicline—nicotine dependence	0.00469	0.00772	CcSEcCtD
Pentoxifylline—Dizziness—Varenicline—nicotine dependence	0.00453	0.00746	CcSEcCtD
Pentoxifylline—Vomiting—Varenicline—nicotine dependence	0.00436	0.00717	CcSEcCtD
Pentoxifylline—Rash—Varenicline—nicotine dependence	0.00432	0.00711	CcSEcCtD
Pentoxifylline—Dermatitis—Varenicline—nicotine dependence	0.00432	0.0071	CcSEcCtD
Pentoxifylline—Headache—Varenicline—nicotine dependence	0.00429	0.00707	CcSEcCtD
Pentoxifylline—Nausea—Varenicline—nicotine dependence	0.00407	0.0067	CcSEcCtD
Pentoxifylline—ADORA2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00367	0.0258	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00312	0.022	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—FGD1—nicotine dependence	0.00267	0.0188	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00241	0.017	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00241	0.017	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00237	0.0167	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00217	0.0153	CbGpPWpGaD
Pentoxifylline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00212	0.0149	CbGpPWpGaD
Pentoxifylline—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00209	0.0147	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00207	0.0146	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00203	0.0143	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00202	0.0142	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00188	0.0133	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00188	0.0133	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00186	0.0131	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—DRD2—nicotine dependence	0.00178	0.0125	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00176	0.0124	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00174	0.0123	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00173	0.0122	CbGpPWpGaD
Pentoxifylline—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00172	0.0121	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00171	0.0121	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00171	0.012	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CYP2A7—nicotine dependence	0.0017	0.0119	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00163	0.0115	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TAS2R16—nicotine dependence	0.0016	0.0113	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00158	0.0111	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—DRD2—nicotine dependence	0.00157	0.0111	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00156	0.011	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.00155	0.0109	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—FGD1—nicotine dependence	0.00148	0.0104	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—FGD1—nicotine dependence	0.00148	0.0104	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00147	0.0103	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00146	0.0103	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—FGD1—nicotine dependence	0.00138	0.00974	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—DRD2—nicotine dependence	0.00137	0.00968	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—FGD1—nicotine dependence	0.00137	0.00963	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00136	0.00959	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—FGD1—nicotine dependence	0.00134	0.00945	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00133	0.00939	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—OPRM1—nicotine dependence	0.00132	0.00926	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—FGD1—nicotine dependence	0.00126	0.00885	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00125	0.0088	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—FGD1—nicotine dependence	0.00124	0.00874	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00124	0.00871	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00113	0.00793	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—DRD2—nicotine dependence	0.00112	0.00788	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.00111	0.00783	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.00107	0.00752	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.00102	0.00715	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TAS2R16—nicotine dependence	0.00101	0.00711	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—FGD1—nicotine dependence	0.00097	0.00683	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000969	0.00682	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000964	0.00679	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—DRD2—nicotine dependence	0.000951	0.0067	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TAS2R16—nicotine dependence	0.000946	0.00666	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TAS2R16—nicotine dependence	0.000935	0.00658	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000914	0.00643	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000901	0.00634	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000874	0.00616	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FGD1—nicotine dependence	0.000873	0.00615	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000794	0.00559	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000794	0.00559	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FGD1—nicotine dependence	0.000793	0.00558	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000771	0.00543	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000743	0.00524	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGD1—nicotine dependence	0.000742	0.00523	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000735	0.00517	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000734	0.00517	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGD1—nicotine dependence	0.000734	0.00517	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.00073	0.00514	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—OPRM1—nicotine dependence	0.000721	0.00508	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKR1B10—nicotine dependence	0.0007	0.00493	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—OPRM1—nicotine dependence	0.000675	0.00475	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—OPRM1—nicotine dependence	0.000667	0.0047	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKR1B10—nicotine dependence	0.000656	0.00462	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKR1B10—nicotine dependence	0.000648	0.00456	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—DRD2—nicotine dependence	0.000632	0.00445	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—DRD2—nicotine dependence	0.000574	0.00404	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000574	0.00404	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—DRD2—nicotine dependence	0.000574	0.00404	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGD1—nicotine dependence	0.000573	0.00404	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—WASF2—nicotine dependence	0.000543	0.00383	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—DRD2—nicotine dependence	0.000538	0.00378	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—DRD2—nicotine dependence	0.000531	0.00374	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—DRD2—nicotine dependence	0.000521	0.00367	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000521	0.00367	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—WASF1—nicotine dependence	0.000521	0.00367	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000506	0.00357	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—WASF2—nicotine dependence	0.000493	0.00347	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—DRD2—nicotine dependence	0.000488	0.00344	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—DRD2—nicotine dependence	0.000482	0.0034	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—WASF1—nicotine dependence	0.000473	0.00333	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—OPRM1—nicotine dependence	0.000469	0.0033	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—WASF2—nicotine dependence	0.000462	0.00325	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—WASF2—nicotine dependence	0.000457	0.00321	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—WASF1—nicotine dependence	0.000443	0.00312	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—WASF1—nicotine dependence	0.000438	0.00308	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—OPRM1—nicotine dependence	0.000426	0.003	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000415	0.00292	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—OPRM1—nicotine dependence	0.000399	0.00281	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—OPRM1—nicotine dependence	0.000394	0.00278	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—DRD2—nicotine dependence	0.000377	0.00265	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—WASF2—nicotine dependence	0.000357	0.00251	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—WASF1—nicotine dependence	0.000342	0.00241	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DRD2—nicotine dependence	0.000339	0.00239	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DRD2—nicotine dependence	0.000308	0.00217	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—OPRM1—nicotine dependence	0.000308	0.00217	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD2—nicotine dependence	0.000288	0.00203	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD2—nicotine dependence	0.000285	0.00201	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD2—nicotine dependence	0.000223	0.00157	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000156	0.0011	CbGpPWpGaD
